Publications 2021

Ahn JM, Zimmermann FM, Arora S, Solberg OG, Angeras O, Rolid K, Rafique M, Aaberge L, Karason K, Okada K, Luikart H, Khush KK, Honda Y, Pijls NHJ, Lee SE, Kim JJ, Park SJ, Gullestad L, Fearon WF (2021)
Prognostic value of comprehensive intracoronary physiology assessment early after heart transplantation
Eur. Heart J., 42 (48), 4918-4929
DOI 10.1093/eurheartj/ehab568

Dreher M, Price D, Gardev A, Peeters P, Arora S, van der Sar-van der Brugge S, Dekhuijzen R, Usmani OS (2021)
Patient perceptions of the re-usable Respimatt(R) Soft Mist (TM) inhaler in current users and those switching to the device: A real-world, non-interventional COPD study
Chronic Respir. Dis., 18, 1479973120986228
DOI 10.1177/1479973120986228

Publications 2020

Bergh N, Gude E, Bartfay SE, Andreassen AK, Arora S, Dahlberg P, Dellgren G, Gullestad L, Gustafsson F, Karasson K, Radegran G, Bollano E, Andersson B (2020)
Invasive haemodynamics in de novo everolimus vs. calcineurin inhibitor heart transplant recipients
ESC Heart Fail., 7 (2), 567-576
DOI 10.1002/ehf2.12608

Gustafsson F, Andreassen AK, Andersson B, Eiskjaer H, Radegran G, Gude E, Jansson K, Solbu D, Karason K, Arora S, Dellgren G, Gullestad L, SCHEDULE Scandinavian Heart Transp (2020)
Everolimus Initiation With Early Calcineurin Inhibitor Withdrawal in De Novo Heart Transplant Recipients: Long-term Follow-up From the Randomized SCHEDULE Study
Transplantation, 104 (1), 154-164
DOI 10.1097/TP.0000000000002702

Nelson LM, Andreassen AK, Arora S, Andersson B, Gude E, Eiskjaer H, Radegran G, Dellgren G, Gullestad L, Gustafsson F (2020)
Mild acute cellular rejection and development of cardiac allograft vasculopathy assessed by intravascular ultrasound and coronary angiography in heart transplant recipients-a SCHEDULE trial substudy
Transpl. Int., 33 (5), 517-528
DOI 10.1111/tri.13577

Publications 2019

Arora S, Ofstad AP, Ulimoen GR, Birkeland KI, Endresen K, Gullestad L, Johansen OE (2019)
Asymptomatic coronary artery disease in a Norwegian cohort with type 2 diabetes: a prospective angiographic study with intravascular ultrasound evaluation
Cardiovasc. Diabetol., 18, 26
DOI 10.1186/s12933-019-0832-2

Norum HM, Michelsen AE, Lekva T, Arora S, Otterdal K, Olsen MB, Kong XY, Gude E, Andreassen AK, Solbu D, Karason K, Dellgren G, Gullestad L, Aukrust P, Ueland T (2019)
Circulating delta-like Notch ligand 1 is correlated with cardiac allograft vasculopathy and suppressed in heart transplant recipients on everolimus-based immunosuppression
Am. J. Transplant., 19 (4), 1050-1060
DOI 10.1111/ajt.15141

Troseid M, Mayerhofer CCK, Broch K, Arora S, Svardal A, Hov JR, Andreassen AK, Gude E, Karason K, Dellgren G, Berge RK, Gullestad L, Aukrust P, Ueland T (2019)
The carnitine-butyrobetaine-TMAO pathway after cardiac transplant: Impact on cardiac allograft vasculopathy and acute rejection
J. Heart Lung Transplant., 38 (10), 1097-1103
DOI 10.1016/j.healun.2019.06.003

Publications 2018

Arora S, Andreassen AK, Karason K, Gustafsson F, Eiskjaer H, Botker HE, Radegran G, Gude E, Ioanes D, Solbu D, Dellgren G, Ueland T, Aukrust P, Gullestad L, SCHEDULE Scandinavian Heart Traspl (2018)
Effect of Everolimus Initiation and Calcineurin Inhibitor Elimination on Cardiac Allograft Vasculopathy in De Novo Heart Transplant Recipients Three-Year Results of a Scandinavian Randomized Trial
Circ.-Heart Fail., 11 (9), e004050
DOI 10.1161/CIRCHEARTFAILURE.117.004050

Publications 2017

Authen AR, Grov I, Karason K, Gustafsson F, Eiskjaer H, Radegran G, Gude E, Jansson K, Dellgren G, Solbu D, Arora S, Andreassen AK, Gullestad L, SCHEDULE Investigators (2017)
Effect of everolimus vs calcineurin inhibitors on quality of life in heart transplant recipients during a 3-year follow-up: Results of a randomized controlled trial (SCHEDULE)
Clin. Transplant., 31 (9), e13038
DOI 10.1111/ctr.13038

Burker BS, Gullestad L, Gude E, Authen AR, Grov I, Hol PK, Andreassen AK, Arora S, Dew MA, Fiane AE, Haraldsen IR, Malt UF, Andersson S (2017)
Cognitive function after heart transplantation: Comparing everolimus-based and calcineurin inhibitor-based regimens
Clin. Transplant., 31 (4), e12927
DOI 10.1111/ctr.12927

Yardley M, Gullestad L, Bendz B, Bjorkelund E, Rolid K, Arora S, Nytroen K (2017)
Long-term effects of high-intensity interval training in heart transplant recipients: A 5-year follow-up study of a randomized controlled trial
Clin. Transplant., 31 (1), e12868
DOI 10.1111/ctr.12868

Publications 2016

Mirza K, Gustafsson F, Gullestad L, Arora S, Andersen C (2016)
Effect of everolimus initiation and early calcineurin inhibitor withdrawal on myocardial FOXP3+regulatory T cells in heart transplantation
Transpl. Immunol., 38, 75-77
DOI 10.1016/j.trim.2016.05.004

Nytroen K, Yardley M, Rolid K, Bjorkelund E, Karason K, Wigh JP, Dall CH, Arora S, Aakhus S, Lunde K, Solberg OG, Gustafsson F, Prescott EIB, Gullestad L (2016)
Design and rationale of the HITTS randomized controlled trial: Effect of High-intensity Interval Training in de novo Heart Transplant Recipients in Scandinavia
Am. Heart J., 172, 96-105
DOI 10.1016/j.ahj.2015.10.011

Solberg OG, Stavem K, Ragnarsson A, Ioanes D, Arora S, Endresen K, Benth JS, Gullestad L, Gude E, Andreassen AK, Aaberge L (2016)
Index of microvascular resistance after early conversion from calcineurin inhibitor to everolimus in heart transplantation: A sub-study to a 1-year randomized trial
J. Heart Lung Transplant., 35 (8), 1010-1017
DOI 10.1016/j.healun.2016.03.002

Publications 2014

Arora S, Gullestad L (2014)
The challenge of allograft vasculopathy in cardiac transplantation
Curr. Opin. Organ Transpl., 19 (5), 508-514
DOI 10.1097/MOT.0000000000000112

Publications 2013

Nytroen K, Rustad LA, Erikstad I, Aukrust P, Ueland T, Lekva T, Gude E, Wilhelmsen N, Hervold A, Aakhus S, Gullestad L, Arora S (2013)
Effect of high-intensity interval training on progression of cardiac allograft vasculopathy
J. Heart Lung Transplant., 32 (11), 1073-1080
DOI 10.1016/j.healun.2013.06.023

Publications 2012

Arora S, Gude E, Sigurdardottir V, Mortensen SA, Eiskjaer H, Riise G, Mared L, Bjortuft O, Ekmehag B, Jansson K, Simonsen S, Aukrust P, Solbu D, Iversen M, Gullestad L (2012)
Improvement in renal function after everolimus introduction and calcineurin inhibitor reduction in maintenance thoracic transplant recipients: The significance of baseline glomerular filtration rate
J. Heart Lung Transplant., 31 (3), 259-265
DOI 10.1016/j.healun.2011.12.010

Arora S, Aarones M, Aakhus S, Skaardal R, Aass H, Aukrust P, Kongsgaard E, Gullestad L (2012)
Peak oxygen uptake during cardiopulmonary exercise testing determines response to cardiac resynchronization therapy
J. Cardiol., 60 (3-4), 228-235
DOI 10.1016/j.jjcc.2012.03.004

Sarvari SI, Gjesdal O, Gude E, Arora S, Andreassen AK, Gullestad L, Geiran O, Edvardsen T (2012)
Early Postoperative Left Ventricular Function by Echocardiographic Strain is a Predictor of 1-Year Mortality in Heart Transplant Recipients
J. Am. Soc. Echocardiogr., 25 (9), 1007-1014
DOI 10.1016/j.echo.2012.05.010

Publications 2011

Arora S, Ueland T, Wennerblom B, Sigurdadottir V, Eiskjaer H, Botker HE, Ekmehag B, Jansson K, Mortensen SA, Saunamaki K, Simonsen S, Gude E, Bendz B, Solbu D, Aukrust P, Gullestad L (2011)
Effect of Everolimus Introduction on Cardiac Allograft Vasculopathy-Results of a Randomized, Multicenter Trial
Transplantation, 92 (2), 235-243
DOI 10.1097/TP.0b013e31822057f1

Publications 2010

Arora S (2010)
Immunological and non-immunological markers of cardiac allograft vasculopathy amongst heart transplant recipients
In Series of dissertations submitted to the Faculty of Medicine, University of Oslo, Unipub, Oslo, no. 934, 1 b. (flere pag.)
BIBSYS 101142978, ISBN 978-82-8072-360-4

Gude E, Andreassen AK, Arora S, Gullestad L, Grov I, Hartmann A, Leivestad T, Fiane AE, Geiran OR, Vardal M, Simonsen S (2010)
Acute renal failure early after heart transplantation: risk factors and clinical consequences
Clin. Transplant., 24 (6), E207-E213
DOI 10.1111/j.1399-0012.2010.01225.x

Gude E, Gullestad L, Arora S, Simonsen S, Hoel I, Hartmann A, Holdaas H, Fiane AE, Geiran OR, Andreassen AK (2010)
Benefit of early conversion from CNI-based to everolimus-based immunosuppression in heart transplantation
J. Heart Lung Transplant., 29 (6), 641-647
DOI 10.1016/j.healun.2010.01.005

Gude E, Simonsen S, Geiran OR, Fiane AE, Gullestad L, Arora S, Relbo A, Andreassen AK (2010)
Pulmonary hypertension in heart transplantation: Discrepant prognostic impact of pre-operative compared with 1-year post-operative right heart hemodynamics
J. Heart Lung Transplant., 29 (2), 216-223
DOI 10.1016/j.healun.2009.08.021

Publications 2009

Arora S, Aukrust P, Andreassen A, Simonsen S, Gude E, Grov I, Geiran O, Fiane A, Guffestad L (2009)
The prognostic importance of modifiable risk factors after heart transplantation
Am. Heart J., 158 (3), 431-436
DOI 10.1016/j.ahj.2009.05.036

Arora S, Aukrust P, Ueland T, Broch K, Simonsen S, Gude E, Fiane AE, Geiran O, Wergeland R, Andreassen AK, Gullestad L (2009)
Elevated serum uric acid levels following heart transplantation predict all-cause and cardiac mortality
Eur. J. Heart Fail., 11 (10), 1005-1013
DOI 10.1093/eurjhf/hfp115

Gjesdal O, Gude E, Arora S, Leivestad T, Andreassen AK, Gullestad L, Aaberge L, Brunvand H, Edvardsen T, Geiran OR, Simonsen S (2009)
Intra-aortic balloon counterpulsation as a bridge to heart transplantation does not impair long-term survival
Eur. J. Heart Fail., 11 (7), 709-714
DOI 10.1093/eurjhf/hfp078

Publications 2008

Arora S, Jenum PA, Aukrust P, Rollag H, Andreassen AK, Simonsen S, Guide E, Fiane AE, Geiran O, Gullestad L (2008)
Pre-transplant Toxoplasma gondii seropositivlty among heart transplant recipients and mortality - Reply
J. Am. Coll. Cardiol., 51 (18), 1827-1828
DOI 10.1016/j.jacc.2008.02.028

Arora S, Nicholls SJ (2008)
ATHEROSCLEROTIC PLAQUE REDUCTION: BLOOD PRESSURE, DYSLIPIDEMIA, ATHEROTHROMBOSIS
Drugs Today, 44 (9), 711-718
DOI 10.1358/dot.2008.44.9.1263999

Publications 2007

Arora S, Andreassen A, Simonsen S, Gude E, Dahl C, Skaardal R, Hoel I, Geiran O, Gullestad L (2007)
Prognostic importance of renal function 1 year after heart transplantation for all-cause and cardiac mortality and development of allograft vasculopathy
Transplantation, 84 (2), 149-154
DOI 10.1097/01.tp.0000268810.61393.2c

Arora S, Gullestad L, Wergeland R, Simonsen S, Holm T, Hognestad A, Ueland T, Geiran O, Andreassen A (2007)
Probrain natriuretic peptide and C-reactive protein as markers of acute rejection, allograft vasculopathy, and mortality in heart transplantation
Transplantation, 83 (10), 1308-1315
DOI 10.1097/01.tp.0000263338.39555.21

Arora S, Jenum PA, Aukrust P, Rollag H, Andreassen AK, Simonsen S, Gude E, Fiane AE, Geiran O, Gullestad L (2007)
Pre-transplant Toxoplasma gondii seropositivity among heart transplant recipients is associated with an increased risk of all-cause and cardiac mortality
J. Am. Coll. Cardiol., 50 (20), 1967-1972
DOI 10.1016/j.jacc.2007.07.068